Health Professional Radio - Podcast
FDA Approval of Nucala for Treatment of Severe Asthma in Children
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:09:13
- Mas informaciones
Informações:
Sinopsis
Dr. Jonathan Steinfeld, global clinical lead for the GSK mepolizumab pediatric asthma indication discusses the recent FDA approval of GSK's Nucala (mepolizumab) the only biologic for use in children as young as 6 years old that have severe eosinophilic asthma.
